Form D · Biotechnology
VentSafe, Inc.
San Francisco, CA · CIK 0002002222
Offering snapshot reported Dec 1, 2023 · SEC filing
- Reported sold
- $20K Offering amount: $500K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 8, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 1, 2023 | Initial | $20,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-498531
Source: Form D, filed Dec 1, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sean Degmetich | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
90 Urbano Drive
San Francisco, CA, 94127
San Francisco, CA, 94127